The 2β2-2β3 loop of anthrax protective antigen contains a dominant neutralizing epitope

Biochemical and Biophysical Research Communications

Volumn 341, Issue 4, 2006, Pages 1164-1171

  Zhang, Jun ^a   Xu, Junjie ^a   Li, Guanlin ^a   Dong, Dayong ^a   Song, Xiaohong ^a   Guo, Qiang ^a   Zhao, Jian ^a   Fu, Ling ^a   Chen, Wei ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Anthrax toxin; Epitope; Neutralizing epitope; Protective antigen

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; ANTIGEN; CHYMOTRYPSIN; EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OLIGOMER; PEPTIDE LIBRARY; TOXIN ANTIBODY; BACTERIAL ANTIGEN; BACTERIAL TOXIN; TRYPSIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; FEMALE; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; ANIMAL; BACILLUS ANTHRACIS; CHEMISTRY; CONSENSUS SEQUENCE; EPITOPE MAPPING; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN SECONDARY STRUCTURE;

ANIMALIA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CHYMOTRYPSIN; CONSENSUS SEQUENCE; EPITOPE MAPPING; EPITOPES; MICE; PROTEIN STRUCTURE, SECONDARY; TRYPSIN;

EID: 32344447272     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.01.080     Document Type: Article

References (32)

1. P.C. Turnbull Anthrax vaccines: past, present and future Vaccine 9 1991 533 539
2. S.H. Leppla Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells Proc. Natl. Acad. Sci. USA 79 1982 3162 3166
3. N.S. Duesbery, C.P. Webb, S.H. Leppla, V.M. Gordon, K.R. Klimpel, T.D. Copeland, N.G. Ahn, M.K. Oskarsson, K. Fukasawa, K.D. Paull, and G.F. Vande Woude Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor Science 280 1998 734 737
4. G. Vitale, R. Pellizzari, C. Recchi, G. Napolitani, M. Mock, and C. Montecucco Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages Biochem. Biophys. Res. Commun. 248 1998 706 711
5. M. Mourez Anthrax toxins Rev. Physiol. Biochem. Pharmacol. 152 2004 135 164
6. P. Ascenzi, P. Visca, G. Ippolito, A. Spallarossa, M. Bolognesi, and C. Montecucco Anthrax toxin: a tripartite lethal combination FEBS Lett. 531 2002 384 388
7. K.A. Bradley, J. Mogridge, M. Mourez, R.J. Collier, and J.A. Young Identification of the cellular receptor for anthrax toxin Nature 414 2001 225 229
8. H.M. Scobie, G.J. Rainey, K.A. Bradley, and J.A. Young Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor Proc. Natl. Acad. Sci. USA 100 2003 5170 5174
9. H.M. Scobie, and J.A.T. Young Interactions between anthrax toxin receptors and protective antigen Curr. Opin. Microbiol. 8 2005 106 112
10. R.N. Bre Molecular basis for improved anthrax vaccines Adv. Drug Deliv. Rev. 57 2005 1266 1292
11. S.F. Little, S.H. Leppla, and E. Cora Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin Infect. Immun. 56 1988 1807 1813
12. N. Mohamed, M. Clagett, J. Li, S. Jones, S. Pincus, G. D'Alia, L. Nardone, M. Babin, G. Spitalny, and L. Casey A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge Infect. Immun. 73 2005 795 802
13. X. Cui, Y. Li, M. Moayeri, G.H. Choi, G.M. Subramanian, X. Li, M. Haley, Y. Fitz, J. Feng, S.M. Banks, S.H. Leppla, and P.Q. Eichacker Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis J. Infect. Dis. 191 2005 422 434
14. F. Wang, P. Ruther, I. Jiang, R. Sawada-Hirai, S.M. Sun, R. Nedellec, P.R. Morrow, and A.S. Kang Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly Hum. Antibodies 13 2004 105 110
15. M.L.M. Pitt, S.F. Little, B.E. Ivins, P. Fellows, J. Barth, J. Hewetson, P. Gibbs, M. Dertzbaugh, and A.M. Friedlander In vitro correlate of immunity in a rabbit model of inhalational anthrax Vaccine 19 2001 4768 4773
16. S. Welkos, S. Little, A. Friedlander, D. Fritz, and P. Fellows The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores Microbiology 147 2001 1677 1685
17. C.K. Cotea, C.A. Rossib, A.S. Kangc, P.R. Morrowc, J.S. Leed, and S.L. Welkosa The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions Vaccine 10 2005 1 19
18. N. Mohamed, J. Li, C.S. Ferreira, S.F. Little, A.M. Friedlander, G.L. Spitalny, and L.S. Casey Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages Infect. Immun. 72 2004 3276 3283
19. E.V. Belova, S.A. Dubilei, T.B. Kravchenko, A.V. Kolesnikov, M. Zakharova, and I.G. Shemiakin Monoclonal antibodies to B. anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro Mol. Gen. Mikrobiol. Virusol. 3 2004 21 26
20. J. Xu, D. Dong, X. Song, M. Ge, G. Li, L. Fu, H. Zhuang, and W. Chen Expression, purification and characterization of the recombinant anthrax protective antigen Chin. J. Biotechnol. 20 2004 652 655
21. Q. Guo, J. Xu, D. Dong, L. Fu, and W. Chen Expression and characterization of the recombinant anthrax lethal factor Acta Microbiol. Sin. 44 2004 749 751
22. C. Petosa, R.J. Collier, K.R. Klimpel, S.H. Leppla, and R.C. Liddington Crystal structure of the anthrax toxin protective antigen Nature 385 1997 833 838
23. 315, in anthrax toxin protective antigen is required for translocation of lethal factor J. Biol. Chem. 269 1994 29039 29046
24. S.F. Little Anthrax vaccines: a development update Biodrugs 19 2005 233 245
25. J.Y. Wang, and M.H. Roehrl Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin Med. Immunol. 24 2005 4
26. G.E. Rhie, M.H. Roehr, M. Mourez, R.J. Collier, J.J. Mekalanos, and J.Y. Wang A dually active anthrax vaccine that confers protection against both bacilli and toxins Proc. Natl. Acad. Sci. USA 100 2003 10925 10930
27. B.A. Aulinger, M.H. Roehrl, J.J. Mekalanos, R.J. Collier, and J.Y. Wang Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines Infect. Immun. 73 2005 3408 3414
28. H.C. Flick-Smith, N.J. Walker, P. Gibson, H. Bullifent, S. Hayward, J. Miller, R.W. Titball, and E.D. Williamson A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection Infect. Immun. 70 2002 1653 1656
29. M.J. Rosovitz, P. Schuck, M. Varughese, A.P. Chopra, V. Mehra, Y. Singh, L.M. McGinnis, and S.H. Leppla Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a nneutralizing monoclonal antibody J. Biol. Chem. 278 2003 30936 30944
30. F. Brossier, M. Levy, A. Landier, P. Lafaye, and M. Mock Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies Infect. Immun. 72 2004 6313 6317
31. S.F. Little, J.M. Novak, J.R. Lowe, S.H. Leppla, Y. Singh, K.R. Klimpel, B.C. Lidgerding, and A.M. Friedlander Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies Microbiology 142 1996 707 715
32. E. Laffly, L. Danjou, F. Condemine, D. Vidal, E. Drouet, M.P. Lefranc, C. Bottex, and P. Thullier Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694 Antimicrob. Agents Chemother. 49 2005 3414 3420